Justin Lewis, MD
Gastroenterology · Portland, ORNPI 1831621929
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Wilson Cook Medical Incorporated at 41.6% of the total. 2025 is the largest year on record at $935, more than ten times the $13 reported in 2021.
Across 25 payments — averaging $53.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wilson Cook Medical Incorporated$556
- Boston Scientific$487
- Terumo Medical Corporation$146
- Johnson & Johnson$68
- ERBE USA Inc$28
- AbbVie$26
- plus $23 from 1 others
What the payments were for
- Travel & lodging$55642%
- Food & beverage$71153%
- Education$685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wilson Cook Medical Incorporated | 2 | $556 |
| Boston Scientific | 17 | $487 |
| Terumo Medical Corporation | 1 | $146 |
| Johnson & Johnson | 1 | $68 |
| ERBE USA Inc | 1 | $28 |
| AbbVie | 2 | $26 |
| Medtronic | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,335 in reported general payments places this provider in the 75th percentile of 220 gastroenterology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 31 | $444 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 32 | $439 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 33 | $425 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Portland
- Donald LumPortland$320K
- Rebecca MatroPortland$154K
- Ian HolmesPortland$102K
- Amy ZhuPortland$72K
- Gregory CotePortland$58K
- Emily JonicaPortland$49K
- Rebecca FauselPortland$29K
- Anil SharmaPortland$14K
- Harry BrayPortland$11K
- Kaveh SharzehiPortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.